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Background: In this present study we decided to consider the prevalence and distribution of
Beijing family in the world using meta-analysis based on systematic review of articles pub-
lished and relation with drug resistance, which will provide more detailed information to
clearly overview the status of this family and transmission of TB.
Methods: This study used the most available article published in literature database includ-
ing PubMed, Science direct, Web of Science, Google Scholar, Biological abs, Iranmedex, and
SID systematically reviewed prevalence of Beijing family. Data analyzed using meta-
analysis with random effects models.
Results: Final analyses included 264 samples that have been selected from 2811 studies.
Overall Beijing family prevalence in world was estimated to be 33.2% (95% CI 31.4–35.2).
Corresponding estimates by continent were Asia 44.7% (39.5–49.8), Europe 27.9% (25.6–
30.1), Africa 12Æ5% (8.9–16.2), and America 8.9% (6.9–10.9). In all world regions, Beijing fam-
ilies were associated with drug resistance 81.37%.
Conclusions: According to the results, prevalence of Beijing family in Asia is higher than
similar studies in other parts of the world and this family is associated with drug resis-
tance. Effective control program is needed in world to control the spread of drug resistance
strains specially Beijing family.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction
Tuberculosis (TB) is a major health problem in the world, and
based on the World Health Organization (WHO) report the
prevalence of TB is 1.7 million cases and the incidence rate
is 9.27 million cases globally as of 2007 [1]. The emergenceof multidrug-resistant tuberculosis (MDR-TB) is going to wor-
sen this problem and is a threat to infectious disease.
TB has been caused by Mycobacterium tuberculosis (MTB).
These bacteria are slow growth and need a well-equipped lab-
oratory for culture and diagnosis. Culture and diagnose of TB
agents are cumbersome and difficult. Therefore, molecularKurdistan
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diagnosis and genotyping.
Spoligotyping is a polymerase chain reaction (PCR)-based
method that was introduced by Kamerbeek in 1997 [2] and
can be used directly for clinical samples without culture. This
technique detects polymorphism in the chromosomal direct
repeat locus in order to diagnose and type the MTB complex.
This method has been used to type isolates in several fam-
ilies, including Beijing, EAI, Haarlem, Lam, T, U, S, X and sev-
eral others [3,4]. Based on reports, spoligotypes have their
own geographical distribution and specifications [4,5]. One
of the most important of them is the Beijing family, published
from Beijing, China, since 1995. However, there are many re-
ports from other parts of the world [6–8]. The Beijing families
of MTB are associated with drug resistance and induce more
severe forms of TB and generally have a higher treatment fail-
ure and relapse than others [6,9–21].
In this present study, it was decided to consider the prev-
alence and distribution of the Beijing family in the world
using meta-analysis based on a systematic review of articles
published between 1997 and 2012. The alternate aim is the
relation with drug resistance and relevant estimates based
on continent estimation and distribution, which will provide
more detailed information to clearly overview the status of
this family and transmission of TB.Materials and methods
Literature identification
The available international and domestic literature database,
which includes PubMed, Sciencedirect, Web of Science,
Google Scholar, Biological abs, Iranmedex, and SID, has been
searched for studies that report the prevalence of the Beijing
family, published in English or the Persian language. The ori-
ginal articles were screened by using the key words tubercu-
losis, Beijing, Molecular epidemiology and Spoligotyping in
combinational or individual formats.Inclusion and exclusion criteria
Studies reporting the prevalence of the Beijing family were
considered. In duplicate articles, the evaluation of the date
was considered. Excluded studies included review articles,
congress abstracts, studies reported in languages other than
English or Persian, and studies that were not available in ab-
stract or full text. Two reviewers searched independently.
When there were disagreements between them in the selec-
tion of articles, they discussed their concerns regarding its
selection for the study.Data extraction
The following data were extracted from the original publica-
tions: first authorandyear of publication, association with drug
resistance, literature database, and study enrollment time and
population, prevalence of the Beijing family, source type
(abstract or full text), and association with drug resistance.Statistical analysis
Prevalence of the Beijing family of TB in all of the studies was
chosen as the main outcome. The variance of prevalence was
computed using binomial distribution. There was heteroge-
neity among studies. I2 and Q statistics tests were used to
check heterogeneity among studies. Meta-analyses with ran-
dom effect model was applied to combine prevalence among
studies. Meta-analyses were carried out using Stata ver. 10.
Stratified analyses were subsequently performed with respect
to the geographic areas and the drug-resistant TB among the
Beijing family isolates [20]. Random effects models were used,
taking into account the possibility of heterogeneity between
studies, which were tested with the Q test and the I2 test. Sub-
group analyses were assessed by chi-square tests for
continents.
Ethical approval
This study project was approved by the Kurdistan University
of Medical Science, scientific board research committee.
Results
In the primary search, 2811 published articles have been
saved in literature by using key word combinations. Articles
that have no information about prevalence or extractable date
were excluded, and finally 264 articles were selected for eval-
uation (Table 1). Out of the 264 articles, 6 were in Persian and
the rest were in English.
In the total of 264 studied articles, the prevalence was
0.33% in 118,348 as indicated in (Table 2).
In considering prevalence based on continent, the Beijing
family is prevalent in Asia 47.91%, as indicated in (Table 3).
There was an association between drug resistance and
prevalence of the Beijing family in the total continents of
81.6 % (Table 2).
In most countries, the same rate of association in relation
to drug resistance was present (Table 3).
There are more reports from China (31.20%) among Asian
countries, and Iran was (14.40%) as indicated in Table 4.
Discussion
This study includes the most recent research with regard to
the prevalence of TB in the world health population. The
importance of TB and the Beijing family is evident for all sci-
entists. The spreading of the Beijing family among different
nationalities and the dynamics of transmission is helpful
for tracking and designing a program for the control of TB.
As shown in Table 1 and 264 articles were identified for
meta-analysis. The difference in percent in the database is lo-
gic based on specialists in publishing medical journals and
publicity. A search using Endnote software was used and
overlap studies were deleted. Therefore, some database sites
such as Pubmed (31.1%) (28.3–33.8) has more published arti-
cles on TB.
Molecular epidemiology establishes a dynamic of trans-
mission of infectious disease. Several molecular techniques
Table 1 – Total searched and selected publication based on available sites in internet.
No. Site totAl Selected ES [95% Conf. Interval]
1 Science direct 258 10 0.200 0.131 0.268
2 Iranmedex 10 5 0.069 0.043 0.096
3 Pubmed 711 146 0.311 0.283 0.338
4 Biological abs 91 6 0.435 0.015 0.854
5 SID 16 1 – – –
6 Google scholar 1530 45 0.344 0.305 0.382
7 Web of Science 195 51 0.445 0.371 0.518
Total 2811 264 – – –
Table 2 – Association of Beijing family with drug resistance based on continents.
Continent Drug resistance association Total
Yes No
Asia 50(82.0%) 11(18.0%) 61(59.22%)
Europe 27(81.8%) 6(18.2%) 33(32.04%)
Africa 4(80.0%) 1(20.0%) 5(4.85%)
America 3(75.0%) 1(25.0%) 4(3.88%)
Total 84(81.6%) 19(18.4%) 103(100%)
Table 3 – Drug resistance association with Beijing family based on study place (country).
Country Drug resistance association Total
Yes No
Bangladesh 1 0 1
Belgium 1 0 1
Bulgaria 0 1 1
Cambodia 3 0 3
China 13 5 18
Colombia 1 0 1
Czech Republic 0 1 1
Estonia 1 0 1
Georgia 1 1 2
Honduras 0 1 1
India 6 1 7
Iran 8 1 9
Japan 0 2 2
Latin America 1 0 1
Myanmar 1 0 1
Netherlands 1 0 1
Pakistan 1 0 1
Poland 1 0 1
Russia 16 1 17
Saudi Arabia 1 0 1
Sierra Leone 1 0 1
South Africa 3 1 4
South Korea 2 1 3
Spain 1 0 1
Sweden 1 1 2
Taiwan 6 1 7
Thailand 1 0 1
Turkey 3 1 4
UK 1 0 1
Uzbekistan and Turkmenistan 1 0 1
Venezuela 1 0 1
Vietnam 6 0 6
Total 84 19 103
81.6% 18.4% 100%
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Table 4 – Distribution of reports in Asian countries.
Country Reports
(%)
Bangladesh 4.00
Cambodia 2.40
China 31.20
India 14.40
Indonesia 1.60
Iran 14.40
Japan 4.00
Kazakhstan 0.80
Myanmar 0.80
Pakistan 1.60
Russia 0.80
Saudi Arabia 1.60
Senegal 0.80
South Korea 3.20
Sri Lanka 0.80
Taiwan 10.40
Thailand 1.60
Uzbekistan and Turkmenistan 0.80
Vietnam 4.80
Total 100.00
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spoligotyping has been used extensively in the world and
database SPODB has been established in order to trace the
migration and dissemination of M. tuberculosis complex in a
given population. Spoligotyping is better than other molecu-
lar methods in that data can be shared between laboratories.
There are a lot of families in the M. tuberculosis complex, and
the best known among them is the Beijing family. The
meta-analysis prevalence of this family is 33.3% (31.4–
35.2%). The extreme data was excluded by statistical analysis.
This type was more prevalent in Asia (44.7%) and lowest in
America (8.9%). In published meta-analysis literature, the
prevalence rate was the same, especially in Asian countries
[5]. The present study is an update used to revise the vision
of the prevalence of TB in the world. In this regard, a glance
at the data indicates that the prevalence from Asia to America
was diminished in transmission. The Beijing family origi-
nated from China; therefore, it is not surprising that the high-
est rate has been reported from this region. In contrast,
America is far from the origin of emergence, so it is logical
that the low prevalence of this type is predictable.
The association of antibiotic resistance and the prevalence
of the Beijing family is controversial. There are a lot of reports
with regard to the relation of the Beijing family and its asso-
ciation with drug resistance [22–24]. On the other hand, some
studies reported no correlation of drug resistance and the Bei-
jing family [25–27]. This study considered all articles and ana-
lyzed them statistically, as shown in Tables 2 and 3) in the
overall Beijing family associated with drug resistance. Overall,
81.60% were associated with drug resistance. Although there
is a difference in the number of reports from the four conti-
nents, the percent is nearly the same in all. As indicated in
the Tables 2 and 3, the highest rates were reported from China
and Russia. In previous meta-analysis done by 16 studies, the
relationship with drug resistance was restricted to some re-gions, not all of the world [5]. In this review, 264 studies were
selected for analysis; therefore, the impact of this statistical
analysis with regard to drug resistance association should
weigh heavily against the total number of published reports.
In conclusion, the prevalence of the Beijing family in the
world population and its association with drug-resistance
has been summarized in this systematic review. The results
of this study indicate the dynamics of transmission of the
Beijing family and its association with drug resistance, and
this information should improve the vision concerning TB
in the world population.
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